Chronic Obstructive Pulmonary Disease News and Research RSS Feed - Chronic Obstructive Pulmonary Disease News and Research

The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.
Prediagnostic lung function impairment common in older asthma patients

Prediagnostic lung function impairment common in older asthma patients

Older adults with newly diagnosed asthma are not only more likely to have pre-existing lung function impairment than younger adults, but they also experience a more rapid decline of lung function, a Danish team reports in Respiratory Medicine. [More]
ICS use may lower risk of mortality from pneumonia and other causes in COPD patients

ICS use may lower risk of mortality from pneumonia and other causes in COPD patients

Treatment of COPD with inhaled corticosteroids (ICS) may decrease the risk of dying from pneumonia and from other causes despite being associated with an increase in the occurrence of pneumonia, according to a new meta-analysis presented at the 2015 American Thoracic Society International Conference. [More]
Mayo Clinic hospitals earn top-tier High Performing distinction in U.S. News & World Report ratings

Mayo Clinic hospitals earn top-tier High Performing distinction in U.S. News & World Report ratings

Mayo Clinic Hospitals in Rochester, Minn, and Phoenix earned the top-tier High Performing distinction in all five common care categories in the latest ratings by U.S. News & World Report. [More]
Enterprise Therapeutics secures additional funding to accelerate drug discovery for treatment of respiratory diseases

Enterprise Therapeutics secures additional funding to accelerate drug discovery for treatment of respiratory diseases

ENTERPRISE THERAPEUTICS Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has secured an additional £2.4m ($3.6m) in Series-A financing. [More]
COPD associated with increased mortality in patients with atrial fibrillation, but not stroke

COPD associated with increased mortality in patients with atrial fibrillation, but not stroke

Chronic obstructive pulmonary disease, or COPD, is associated with increased risk of dying from a cardiovascular disease such as heart failure or a heart attack, as well as diseases not associated with the heart. However, COPD is not by itself associated with increased likelihood of having a stroke or a systemic embolism, according to a new research study. [More]
National Jewish Health researcher calls for men to be included in osteoporosis screening guidelines

National Jewish Health researcher calls for men to be included in osteoporosis screening guidelines

Most people associate osteoporosis with women. But the truth is, one in four men over the age of 50 will break a bone as a result of this condition. That's more men than will have prostate cancer, according to the National Osteoporosis Foundation. [More]
Pulmonary rehabilitation treatment benefits patients with OSA syndrome

Pulmonary rehabilitation treatment benefits patients with OSA syndrome

Pulmonary rehabilitation (PR) treatment could be a valuable addition to comprehensive therapy in patients with obstructive sleep apnea (OSA) syndrome, according to a new study. The study was presented at the 2015 American Thoracic Society International Conference. [More]
IQWiG examines the added benefit of aclidinium bromide/formoterol drug combination in COPD patients

IQWiG examines the added benefit of aclidinium bromide/formoterol drug combination in COPD patients

The fixed-dose combination aclidinium bromide/formoterol has been approved since November 2014 for long-term treatment of adults with chronic obstructive pulmonary disease (COPD). [More]
Boehringer Ingelheim, Sutter Health announce health care innovation collaboration

Boehringer Ingelheim, Sutter Health announce health care innovation collaboration

Boehringer Ingelheim, a family-owned biopharmaceutical company, and Sutter Health, a not-for-profit health system in Northern California, today announced the start of a five-year research and health care innovation collaboration, which will explore and test the value of digital health solutions, mobile technologies, and insights from advanced data analytics in the delivery of health care. [More]
Kaiser Permanente, Intermountain Healthcare to participate in U.S. News Hospital Outcome Data Disclosure Program

Kaiser Permanente, Intermountain Healthcare to participate in U.S. News Hospital Outcome Data Disclosure Program

U.S. News & World Report, publisher of Best Hospitals and Best Children's Hospitals, today announced that Kaiser Permanente and Intermountain Healthcare will participate in the U.S. News Hospital Outcome Data Disclosure Program, a new data-collection initiative designed to evaluate hospitals more completely and give patients better information about the hospitals in their communities. [More]
ResMed launches Lumis series of noninvasive ventilation devices to manage respiratory stability of patients

ResMed launches Lumis series of noninvasive ventilation devices to manage respiratory stability of patients

ResMed today announced its Lumis series of noninvasive ventilation devices that combine personalized, simplified therapy with powerful wireless connected care capabilities. The Lumis series builds upon ResMed's legacy of innovation as a new option for patients with respiratory challenges who are not dependent on continuous ventilation. [More]
Scientists test effectiveness of new method for treating COPD

Scientists test effectiveness of new method for treating COPD

Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating chronic obstructive pulmonary disease (COPD) on ex vivo 3D human lung tissue cultures (3D-LTCs). The results have now been published in the European Respiratory Journal. [More]
Adult survivors of preterm births at higher risk of developing COPD

Adult survivors of preterm births at higher risk of developing COPD

Adult survivors of preterm births may have a lung capacity that resembles the healthy elderly or casual smokers by the time they reach their early 20s, according to a University of Oregon study. [More]
Gas naturally produced within our bodies reduces severity of RSV infection, UTMB study finds

Gas naturally produced within our bodies reduces severity of RSV infection, UTMB study finds

A new study from the University of Texas Medical Branch at Galveston is the first to show that hydrogen sulfide, a gas produced naturally within our bodies, reduces the severity of respiratory syncytial virus, or RSV. [More]
UTMB study highlights current use of oxygen therapy in patents with COPD

UTMB study highlights current use of oxygen therapy in patents with COPD

A new study about the use of oxygen to treat chronic obstructive pulmonary disease from The University of Texas Medical Branch at Galveston found that the majority of patients receiving oxygen therapy were low-income, non-Hispanic white females about 75 years old with two or more other health conditions. [More]
Cardiff scientists make breakthrough asthma discovery

Cardiff scientists make breakthrough asthma discovery

Cardiff University scientists have for the first time identified the potential root cause of asthma and an existing drug that offers a new treatment. [More]
Cardiff scientists identify potential root cause of asthma and highlight new treatment option

Cardiff scientists identify potential root cause of asthma and highlight new treatment option

Cardiff University scientists have for the first time identified the potential root cause of asthma and an existing drug that offers a new treatment. [More]
New study describes way to regenerate lung tissue after injury

New study describes way to regenerate lung tissue after injury

A new collaborative study describes a way that lung tissue can regenerate after injury. The team found that lung tissue has more dexterity in repairing tissue than once thought. [More]
LA BioMed scientist awarded $80,000 to study effectiveness of pulmonary rehab in treating COPD

LA BioMed scientist awarded $80,000 to study effectiveness of pulmonary rehab in treating COPD

The ATS Foundation and Breathe California of Los Angeles have awarded $80,000 to Harry Rossiter, PhD, a lead researcher at the Los Angeles Biomedical Research Institute, to study the effectiveness of pulmonary rehabilitation in reducing chronic obstructive pulmonary disease (COPD) symptoms in an underserved population in Los Angeles. [More]
New ERS and ATS statement highlights current state, future research directions in COPD

New ERS and ATS statement highlights current state, future research directions in COPD

The European Respiratory Society and American Thoracic Society have published a statement describing the current evidence on the diagnosis, assessment and management of chronic obstructive pulmonary disease (COPD), identifying gaps in knowledge and making recommendations for the directions of future research. [More]
Advertisement
Advertisement